IPO Traffic: Week Ending Feb. 8, 2019

Lead Manager/ # of Price Range Dollar SCOOP
New Filings (Proposed Symbol) Joint-Lead Managers Shares Low High Volume Ratings
Avantor (TBA) Goldman Sachs/ J.P. Morgan $100.00 n.a.
ShockWave Medical (SWAV) Morgan Stanley/ BofA Merrill Lynch $70.00 n.a.
Tortoise Acquisition (SHLL.U) (u) Barclays/ Goldman Sachs/ UBS Investment Bank 22.50 $10.00 $10.00 $225.00 n.a.
n.a. (not available)
TBA (to be announced)
u – unit offering
Postponed
None
Withdrawn
None
New Terms
Avedro (AVDR) BofA Merrill Lynch/ J.P. Morgan 5.00 $14.00 $16.00 $75.00 S/O
Cibus (CBUS) Morgan Stanley/ BofA Merrill Lynch/ Piper Jaffray 6.67 $14.00 $16.00 $100.00 S/O
Hoth Therapeutics (HOTH) Laidlaw & Company (UK) Ltd. 1.25 $5.50 $6.50 $7.50 S/O
IMAC Holdings (IMACW) Dawson James Securities/ Cuttone 1.70 $0.00 $0.00 $0.00 S/O
Stealth BioTherapeutics (MITO) Jefferies/ Evercore ISI/ BMO Capital Markets 6.20 $12.00 $14.00 $80.60 S/O
TCR2 Therapeutic (TCRR) Jefferies/ Leerink Partners/ BMO Capital Markets 5.00 $14.00 $16.00 $75.00 S/O
S/O (Subscribers Only)
IPOs Priced Lead Shares Amount Offer Close %
Week of Feb. 4, 2019 Manager(s) Offered Raised Price 2/8/19 Change
Gossamer Bio (GOSS) BofA Merrill Lynch/ Leerink Partners/ Barclays/ Evercore ISI 17.25 $276.00 $16.00 $17.94 12.13%
Wealthbridge Acquisition (HHHHU) (u) Chardan 5.00 $50.00 $10.00 $10.03 0.30%
Monocle Acquisition (MNCLU) (u) Cowen/ Chardan 15.00 $150.00 $10.00 $10.02 0.20%
RMG Acquisition (RMG.U) (u) Deutsche Bank Securities 20.00 $200.00 $10.00 $10.00 0.00%
Harpoon Therapeutics (HARP) Citigroup/ Leerink Partners 5.40 $75.60 $14.00 $13.50 -3.57%
Alector  (ALEC) Morgan Stanley/ BofA Merrill Lynch/ Cowen/ Barclays 9.25 $175.75 $19.00 $16.30 -14.21%
u – unit offering